Home / Health Technology / Needle & Syringes, Catheters, Cannula & IV Sets Manufacturing – DPR

Needle & Syringes, Catheters, Cannula & IV Sets Manufacturing - DPR

59,000.00

Short Description

Build a Needle Syringes Catheters Cannula & IV Sets Manufacturing line with a bank-ready DPR or fund-ready Business Plan—market & pricing, material routes, process/ops design, compliance/claims guidance, and 5-year financials. Delivery: 12–15 working days.

Detailed Description

Needle, syringe, catheter, cannula, and IV set manufacturing refers to the production of sterile, single-use medical disposables used for drug delivery, fluid infusion, blood collection, and various diagnostic and therapeutic procedures. These products form the backbone of modern healthcare delivery and are used across hospitals, clinics, diagnostic centers, emergency care units, ambulatory surgical centers, and home healthcare settings. Due to their direct contact with the human body, medical disposables are manufactured under highly regulated conditions to ensure safety, sterility, precision, and consistent performance. The product range includes hypodermic needles, disposable syringes (insulin syringes, auto-disable syringes, standard syringes), IV cannulas, scalp vein sets, infusion sets, urinary catheters, and related tubing accessories. Based on application, these products are used for injections, vaccinations, intravenous therapy, blood transfusion, anesthesia delivery, dialysis, urinary drainage, and critical care monitoring. The increasing preference for single-use medical devices to prevent hospital-acquired infections has significantly strengthened demand across healthcare systems. Manufacturing involves precision engineering and strict quality control. Core processes include medical-grade polymer processing, stainless steel needle fabrication, injection molding, automated assembly, sterilization, and tamper-proof packaging. Technologies such as high-speed injection molding machines, automated needle grinding and beveling systems, robotic assembly lines, and sterilization methods like ethylene oxide (ETO) and gamma irradiation are widely used. Production is carried out in controlled cleanroom environments to comply with international medical device standards. India has become a global manufacturing hub for medical disposables due to cost-efficient production, skilled manpower, expanding healthcare infrastructure, and compliance with global certifications such as ISO 13485, CE marking, and US FDA standards. Government initiatives promoting domestic medical device manufacturing and export-oriented production have further strengthened the growth outlook for this sector. Growth Drivers

  • Rising demand for single-use medical disposables to prevent cross-infection
  • Expansion of hospitals, clinics, and diagnostic centers globally
  • Large-scale vaccination and immunization programs
  • Increasing prevalence of chronic diseases requiring regular injections and infusions
  • Growth of home healthcare and ambulatory care services
  • Government support for domestic medical device manufacturing
Market Size & Outlook Global Market:
  • The global disposable syringes market was valued at approximately USD 15.81 billion in 2024 and is projected to grow to around USD 28.27 billion by 2033, exhibiting a CAGR of 6.8% from 2025 to 2033.
  • The broader IV disposables market (which includes IV sets, infusion sets, and related consumables) is estimated to be valued at around USD 21.2 billion in 2025 and is projected to reach USD 64.8 billion by 2035, growing at a CAGR of 11.8% (2025-2035).
India Market:
  • The India medical disposables market (which includes syringes, needles, catheters, IV sets, etc.) was valued at around USD 21.17 billion in 2024 and is projected to reach nearly USD 48.20 billion by 2033, at a CAGR of 8.84% (2025-2033).
  • Specifically, the India catheter market generated approximately USD 2,960.2 million in 2024 and is expected to grow to about USD 4,610.9 million by 2030, at roughly 7.7% CAGR (2025-2030).

  • This business is suitable for medical device manufacturers, MSMEs, healthcare entrepreneurs, export-oriented units, polymer processing companies, and investors seeking entry into the high-volume, regulated healthcare manufacturing sector.
  • It is also attractive for businesses targeting government tenders and global healthcare supply chains.

Description

Needle, syringe, catheter, cannula, and IV set manufacturing refers to the production of sterile, single-use medical disposables used for drug delivery, fluid infusion, blood collection, and various diagnostic and therapeutic procedures. These products form the backbone of modern healthcare delivery and are used across hospitals, clinics, diagnostic centers, emergency care units, ambulatory surgical centers, and home healthcare settings. Due to their direct contact with the human body, medical disposables are manufactured under highly regulated conditions to ensure safety, sterility, precision, and consistent performance.

The product range includes hypodermic needles, disposable syringes (insulin syringes, auto-disable syringes, standard syringes), IV cannulas, scalp vein sets, infusion sets, urinary catheters, and related tubing accessories. Based on application, these products are used for injections, vaccinations, intravenous therapy, blood transfusion, anesthesia delivery, dialysis, urinary drainage, and critical care monitoring. The increasing preference for single-use medical devices to prevent hospital-acquired infections has significantly strengthened demand across healthcare systems.

Manufacturing involves precision engineering and strict quality control. Core processes include medical-grade polymer processing, stainless steel needle fabrication, injection molding, automated assembly, sterilization, and tamper-proof packaging. Technologies such as high-speed injection molding machines, automated needle grinding and beveling systems, robotic assembly lines, and sterilization methods like ethylene oxide (ETO) and gamma irradiation are widely used. Production is carried out in controlled cleanroom environments to comply with international medical device standards.

India has become a global manufacturing hub for medical disposables due to cost-efficient production, skilled manpower, expanding healthcare infrastructure, and compliance with global certifications such as ISO 13485, CE marking, and US FDA standards. Government initiatives promoting domestic medical device manufacturing and export-oriented production have further strengthened the growth outlook for this sector.

Growth Drivers

  • Rising demand for single-use medical disposables to prevent cross-infection
  • Expansion of hospitals, clinics, and diagnostic centers globally
  • Large-scale vaccination and immunization programs
  • Increasing prevalence of chronic diseases requiring regular injections and infusions
  • Growth of home healthcare and ambulatory care services
  • Government support for domestic medical device manufacturing

Market Size & Outlook

Global Market:

  • The global disposable syringes market was valued at approximately USD 15.81 billion in 2024 and is projected to grow to around USD 28.27 billion by 2033, exhibiting a CAGR of 6.8% from 2025 to 2033.
  • The broader IV disposables market (which includes IV sets, infusion sets, and related consumables) is estimated to be valued at around USD 21.2 billion in 2025 and is projected to reach USD 64.8 billion by 2035, growing at a CAGR of 11.8% (2025-2035).

India Market:

  • The India medical disposables market (which includes syringes, needles, catheters, IV sets, etc.) was valued at around USD 21.17 billion in 2024 and is projected to reach nearly USD 48.20 billion by 2033, at a CAGR of 8.84% (2025-2033).
  • Specifically, the India catheter market generated approximately USD 2,960.2 million in 2024 and is expected to grow to about USD 4,610.9 million by 2030, at roughly 7.7% CAGR (2025-2030).

The project reports provide detailed insights into:

  • Industrial overview and market feasibility
  • Technical and manufacturing feasibility
  • Cleanroom, sterilization, and regulatory requirements
  • Sales feasibility and export market positioning
  • Infrastructure, utilities, and operational planning

These reports offer a comprehensive feasibility analysis with structured business models and implementation strategies.

  • This report functions as a practical, step-by-step execution guide for setting up a needle, syringe, and medical disposables manufacturing unit.
  • It covers everything from regulatory approvals and technology selection to plant layout, production planning, quality systems, and go-to-market strategy.
  • Kick-off (optional) — 45-min Expert Call add-on to align tech route, yields, and channel focus.
  • Research & Modeling — Market, CEA ops blueprint, and financials tailored to your plan.
  • Draft Delivery — Review together; 1st revision free.
  • Final Handover — DPR/Business Plan PDF (and Editable Files if selected).
  • DPR: ₹59,000Delivery: 12–15 working days

  • Business Plan: ₹59,000Delivery: 12–15 working days

  • Add-ons: Customization ₹3,500 · Expert Call ₹2,500 · Editable Files ₹4,500 · Extra Revisions ₹1,500 (first revision free)
    Delivery Mode: Secure email/download link. Support: Email for clarifications.

Is needle and syringe manufacturing a viable business?

Yes. Continuous demand from healthcare systems, immunization programs, and exports ensures long-term stability and scalability.

What are the major end-use sectors?

Hospitals, clinics, diagnostic centers, vaccination programs, home healthcare, and export markets.

Are bank loans and funding options available?

Yes. The project reports are structured to support MSME loans, term loans, and investor funding proposals.

What approvals are required?

CDSCO registration, ISO 13485 certification, pollution control approvals, sterilization validation, and applicable export certifications.